MeMed BV®Aiding Hospitalists with Clinical Decision-Making
MeMed BV provides rapid and accurate differentiation between bacterial and viral infections, aiding hospitalists in making quick and confident admission and discharge decisions for patients with suspected acute infection. |
Suspected Acute Infections:
A Hospitalist’s Complex Puzzle
Admitting the right patients can be complex and challenging¹
Clinical uncertainty is often high, complicating decision-making²
Bed shortages are a persistent issue, especially during winter months³ ⁴
Healthcare-associated infections (HAIs) often complicate prolonged hospital stays ⁵
MeMed BV® May Optimize Bed Usage, Shorten Length of Stay, and Reduce the Risk of Hospital Acquired Infection
MeMed BV can support decision making for busy and understaffed hospitalists⁶ ⁷ ⁸
MeMed BV® Can help suspected sepsis patient management in hemodynamically stable patients⁹
Bacterial MeMed BV Score may help with accelerating therapy initiation.
Viral MeMed BV score may help with early discharge and therapy de-escalation.
Sepsis alerts are sensitive but not specific - Only 1/6 are diagnosed as septic¹²
1/5 of all deaths are related to sepsis¹³
Patient cost ranges from $18K to $51K based on time of detection¹⁴
MeMed BV® Can Potentially Help Determine the Infection Etiology in COPD Exacerbations
Overuse of ABXs is prevalent and misuse may be harmful in COPD patients.¹⁵
BV can accelerate therapy initiation in case of bacterial results. BV is already integrated into the treatment protocol for managing COPD exacerbations at a mid-sized hospital.
MeMed BV® is indicated for use in patients presenting to the emergency department or urgent care center and with samples collected at hospital admission from patients with suspected acute bacterial or viral infection, who have had symptoms for less than seven days. The test is not intended as a standalone diagnostic test, is not intended to identify specific pathogens or predict disease course.
Schedule a demo
References
1. Daniels et al. Journal of General Internal Medicine, 2018
2. Van den Bruel et al. Lancet, 2010
3. CDC 2024 https://www.cdc.gov/ncird/whats-new/track-hospital-capacity.html
4. The Guardian, 2019. https://www.theguardian.com/society/2019/dec/02/nhs-winter-crisis-extra-beds-created-by-52-per-cent-of-uk-hospitals
5. B. H. Tess et al. European Journal of Clinical Microbiology & Infectious Diseases, 1993
6. Kalmovich et al. Biomedicines, 2023.
7. Bachur et al. JACEP OPEN, 2024.
8. Ashkenazi–Hoffnung et al. EJCMID, 2018
9. Angel et al. Annals of emergency Medicine, 2023
10. Routsi et al. Journal of Antimicrobial Chemotherapy, 2020
11. Niimura et al. J Pharm Pharm Sci, 2018
12. Prescott et al. JAMA network, 2022
13. World Health Organization(WHO). 2024 https://www.who.int/news-room/fact-sheets/detail/sepsis
14. Paoli et al. Crit Care Med, 2018
15. Vollenweider et al. Cochrane Database Syst Rev 2018 doi: 10.1002/14651858.CD010257.pub2
16. Pascual-Guardia et al. Archivos de Bronconeumologia 2023 DOI: 10.1016/j.arbres.2022.09.005
© 2024 MeMed, Ltd. All rights reserved.